132 related articles for article (PubMed ID: 6435908)
1. Neutrophil chemotactic factor of anaphylaxis (NCF-A) release in aspirin-induced asthma.
Ortolani C; Capsoni F; Restuccia M; Pastorello E; Riboldi PS; Zocchi M; Zanussi C
Clin Allergy; 1984 Sep; 14(5):443-52. PubMed ID: 6435908
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of neutrophil chemotactic activity in aspirin-induced asthma.
Hollingsworth HM; Downing ET; Braman SS; Glassroth J; Binder R; Center DM
Am Rev Respir Dis; 1984 Sep; 130(3):373-9. PubMed ID: 6433757
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of aspirin-induced bronchoconstriction by sodium cromoglycate inhalation.
Martelli NA; Usandivaras G
Thorax; 1977 Dec; 32(6):684-90. PubMed ID: 414371
[TBL] [Abstract][Full Text] [Related]
4. Serum neutrophil chemotactic activity (NCA) during aspirin-induced bronchoconstriction.
Grzelewska-Rzymowska I; Szmidt M; Rozniecki J; Grzegorczyk J
Allergol Immunopathol (Madr); 1988; 16(2):99-103. PubMed ID: 3293381
[TBL] [Abstract][Full Text] [Related]
5. Enhanced serum neutrophil chemotactic activity was noted in both early and late asthmatic responses during lysine-aspirin bronchoprovocation test in ASA-sensitive asthmatic patients.
Kim SS; Park HS; Yoon HJ; Lee YM; Lee SK; Nahm DH
J Korean Med Sci; 2003 Feb; 18(1):42-7. PubMed ID: 12589085
[TBL] [Abstract][Full Text] [Related]
6. Adenosine-induced bronchoconstriction in asthma: role of mast cell-mediator release.
Cushley MJ; Holgate ST
J Allergy Clin Immunol; 1985 Feb; 75(2):272-8. PubMed ID: 2981912
[TBL] [Abstract][Full Text] [Related]
7. Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma.
Howarth PH; Durham SR; Lee TH; Kay AB; Church MK; Holgate ST
Am Rev Respir Dis; 1985 Nov; 132(5):986-92. PubMed ID: 2932989
[TBL] [Abstract][Full Text] [Related]
8. [Neutrophil chemotactic activity after administration of aspirin during aspirin tolerance in patients with asthma and aspirin hypersensitivity].
Szmidt M; Grzelewska-Rzymowska I; Rozniecki J; Grzegorczyk J
Pneumonol Alergol Pol; 1991; 59(1-2):16-21. PubMed ID: 1843881
[TBL] [Abstract][Full Text] [Related]
9. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma.
Yoshida S; Amayasu H; Sakamoto H; Onuma K; Shoji T; Nakagawa H; Tajima T
Ann Allergy Asthma Immunol; 1998 Feb; 80(2):171-6. PubMed ID: 9494450
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil chemotactic activity in toluene diisocyanate (TDI)-induced asthma.
Sastre J; Banks DE; Lopez M; Barkman HW; Salvaggio JE
J Allergy Clin Immunol; 1990 Mar; 85(3):567-72. PubMed ID: 2155957
[TBL] [Abstract][Full Text] [Related]
11. Exercise-induced release of histamine and neutrophil chemotactic factor in atopic asthmatics.
Lee TH; Brown MJ; Nagy L; Causon R; Walport MJ; Kay AB
J Allergy Clin Immunol; 1982 Aug; 70(2):73-81. PubMed ID: 6178768
[TBL] [Abstract][Full Text] [Related]
12. Effect of salbutamol and inhaled sodium cromoglycate on the airway and neutrophil chemotactic activity in "fog"induced bronchospasm.
Moscato G; Rampulla C; Dellabianca A; Zanotti E; Candura S
J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):382-8. PubMed ID: 3139728
[TBL] [Abstract][Full Text] [Related]
13. Modulation of release of neutrophil chemotactic factor (NCF).
Orr TS; Elliott EV; Altounyan RE; Stern MA
Clin Allergy; 1980 Jul; 10 Suppl():491-6. PubMed ID: 6821511
[No Abstract] [Full Text] [Related]
14. Bronchial asthma and the neutrophil chemotactic factor.
Lee TH; Kay AB
Clin Allergy; 1982 Oct; 12 Suppl():39-45. PubMed ID: 6183024
[TBL] [Abstract][Full Text] [Related]
15. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin.
Israel E; Fischer AR; Rosenberg MA; Lilly CM; Callery JC; Shapiro J; Cohn J; Rubin P; Drazen JM
Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1447-51. PubMed ID: 8256883
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of platelet activation markers in aspirin-sensitive asthmatics and normal subjects.
Taylor ML; Misso NL; Stewart GA; Thompson PJ
Clin Exp Allergy; 1996 Feb; 26(2):202-15. PubMed ID: 8835129
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of leukocyte cytotoxicity after exercise-induced asthma.
Moqbel R; Durham SR; Shaw RJ; Walsh GM; MacDonald AJ; Mackay JA; Carroll MP; Kay AB
Am Rev Respir Dis; 1986 Apr; 133(4):609-13. PubMed ID: 3083743
[TBL] [Abstract][Full Text] [Related]
18. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients.
Obase Y; Shimoda T; Tomari SY; Mitsuta K; Kawano T; Matsuse H; Kohno S
Chest; 2002 Jan; 121(1):143-50. PubMed ID: 11796443
[TBL] [Abstract][Full Text] [Related]
19. [The influence of misoprostol on post-aspirin bronchoconstriction in patients with aspirin sensitive asthma].
Szmidt M; Wasiak W
Pneumonol Alergol Pol; 1995; 63(9-10):544-52. PubMed ID: 8620177
[TBL] [Abstract][Full Text] [Related]
20. Bronchial challenge with adenosine causes the release of serum neutrophil chemotactic factor in asthma.
Driver AG; Kukoly CA; Metzger WJ; Mustafa SJ
Am Rev Respir Dis; 1991 May; 143(5 Pt 1):1002-7. PubMed ID: 2024808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
